Methotrexate fixed dosing protocol for ambulatory treatment of ectopic pregnancy
Reproductive Sciences · 2025
DOI: 10.1007/s43032-024-01768-5 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Reproductive Sciences, 2025. Verfasst von Christine Doran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rock Creek Medical Office, Kaiser Permanente Colorado, 280 Exempla Circle, Lafayette, Denver, CO, 80516, USA. Hauptthemen laut MEDLINE: Methotrexate, Pregnancy, Ectopic, Abortifacient Agents, Nonsteroidal, Ambulatory Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rock Creek Medical Office, Kaiser Permanente Colorado, 280 Exempla Circle, Lafayette, Denver, CO, 80516, USA.
- Rock Creek Medical Office, Kaiser Permanente Colorado, 280 Exempla Circle, Lafayette, Denver, CO, 80516, USA. Christy.L.Pratt@kp.org.
ORCID-Profile: Christine Doran, Christy Pratt, Thomas Delate
Zitieren
APA
Doran, C., Pratt, C., Delate, T., & Nazareth, S. (2025). Methotrexate fixed dosing protocol for ambulatory treatment of ectopic pregnancy. Reproductive Sciences. https://doi.org/10.1007/s43032-024-01768-5
Vancouver
Doran C, Pratt C, Delate T, Nazareth S. Methotrexate fixed dosing protocol for ambulatory treatment of ectopic pregnancy. Reproductive Sciences. 2025. doi:10.1007/s43032-024-01768-5
BibTeX
@article{Doran2025,
author = {Doran, Christine and Pratt, Christy and Delate, Thomas and Nazareth, Sonja},
title = {Methotrexate fixed dosing protocol for ambulatory treatment of ectopic pregnancy},
journal = {Reproductive Sciences},
year = {2025},
doi = {10.1007/s43032-024-01768-5}
}
EUVIMED